Subscription Box
Email
First name
Last name
Phone

 

MRDAF.OBChart: 1 yr - 3 mo - 5 dy
Last 0.36
Change -0.01
Open 0.375
Day High 0.375
Day Low 0.35
Vol 72500
Last updated 1/10/2005 at 3:46pm
Data Delayed 15 minutes

 

Meridian Recieves Standard and Poor's Complete Corporate Listing
3/17/2004
Meridian Co., Ltd. ("Meridian" or the "Company") (NASD
OTC-BB: MRDAF) a leading supplier of integrative medical devices, is
pleased to announce today that the Editorial Board of Standard and
Poor's ("S&P") approved Meridian for a complete corporate listing and
description in the Standard and Poor's Corporation Records.
     Additionally, Meridian will have its corporate description
published in Standard and Poor's Daily News Section. S&P also will
initiate financial coverage of Meridian as part of the S&P Market
Access Program, including coverage of Meridian on the S&P Internet
site, www.advisorinsight.com, the S&P Marketscope and the electronic
version of the S&P Stock Guide database. Additionally, S&P's coverage
of Meridian will appear on the highly trafficked OTC Bulletin Board
Internet site, www.otcbb.com.
     Standard & Poor's Corporation Records is a recognized securities
manual for the "Blue Sky" Standard Manual Exemption for secondary
trading in more than 35 states, Meridian currently qualifies for this
Exemption in 47 states. Meridian's listing in Standard & Poor's
Corporation Records should assist the brokerage and investment
communities in making a market for Meridian's stock. It is recommended
that brokers check with their compliance officers or legal counsel for
applicable "Blue Sky" laws and regulations pertaining to them.

     About Meridian

     Meridian is an established leader in the research, development,
manufacturing and sales of integrative medical devices successfully
marketed to a wide variety of health care practitioners worldwide. The
products have FDA and other recognized regulatory approvals as well as
18 registered patents on its technology. The Company is committed to
ongoing clinical research for the globalization and advancement of
integrative medical products that contribute to the better health of
humanity.
     This release contains "forward looking statements" within the
meaning of Section 27A of the Securities Act of 1933 and Section 21B
of the Securities Exchange Act of 1934. Any statements that express or
involve discussions with respect to predictions, expectations,
beliefs, plans, projections, objectives, goals, assumptions or future
events or performance are not statements of historical fact and may be
"forward looking statements." Forward looking statements are based on
expectations, estimates and projections at the time the statements are
made that involve a number of risks and uncertainties which could
cause actual results or events to differ materially from those
presently anticipated.

Contacts:

Meridian Co., Ltd.
Craig Auringer, 604-647-0044
or Toll Free: 1-866-802-1222
Website: meridianmedical.ca

 

 

 

 

 

 

 

 

 

 

c 2004 Belgium Medical, Inc. All rights reserved. Terms of Use and Disclaimer